Middle East Market Access: SFDA & MoHAP Compliance Consulting for EU Exporters.

SFDA-Ready eCTD Dossiers, Climatic Zone IVb Validation, and Flawless MoHAP e-Portal Onboarding.

Request a Dossier Gap Audit Explore Access Pathways

Outbound Regulatory Compliance Consulting for European Lifescience Innovators.

For European pharmaceutical, biotech, and medical device SMEs, the Middle East represents a highly lucrative expansion frontier. However, achieving compliant market entry requires an elite technical translator to navigate distinct, dual-track regulatory barriers:

The GCC Dossier Hurdle

  • eCTD Module 3 Misalignment:
    Unaligned chemistry, manufacturing, and control (CMC) data formats trigger immediate portal rejections and costly dossier freezes.
  • Climatic Zone IVb Mandates:
    Mandatory drug stability protocols must be meticulously proven and documented under strict heat and humidity parameters (30°C / 75% RH).

The Regional Compliance Maze

  • Sanctions & Export Control:
    High-complexity environments (such as Syria and Iraq) require deep chemical dual-use (EU Reg 2021/821) and BAFA pre-clearance.
  • Consular Legalization Loop:
    Multi-step embassy legalizations of Site Master Files (SMF) and GMP certificates in Berlin must be flawlessly coordinated.

The LGP Regulatory Access Shield

Operating with a deep foundation in German QA/GMP systems, Levant Gate Pharma UG uncouples your commercial timeline from regulatory friction, acting as your outsourced regional regulatory department:

Pre-Audit & Dossier Re-Engineering: We do not simply read regulations; we systematically pre-audit and re-engineer your technical dossiers before submission to ensure they are flawless.

Outsourced Portal Onboarding: We manage the administrative and technical uploads directly into the complex SFDA (Saudi Arabia) and MoHAP (UAE) e-services registries.

Frictionless Embassy Clearance: We manage the legal securement of Free Sales Certificates (FSC), CPPs, and SMFs to prevent custom delays at Middle Eastern ports of entry.

CORE REGULATORY CONSULTING WORKFLOWS

eCTD Dossier Alignment


Key Deliverable:
📁 Submission-Ready eCTD Dossier Package

  • Pre-audit CMC data to preemptively resolve authority queries before submission.
  • Re-map Module 3 to match the precise portal e-services of the SFDA (Saudi) and MoHAP (UAE).
  • Leverage EMA approvals to trigger accelerated regional fast-track pathways.

Zone IVb Stability Validation

Key Deliverable:
🌡️ Climatic Zone IVb Compliance Report

  • Assess stability protocols against the strict 30°C / 75% RH GCC mandates.
  • Draft technical rationales and justification reports for any missing stability datasets.
  • Review packaging barriers to guarantee product integrity under extreme heat-zone conditions

SMF & Legalization Loop


Key Deliverable:
🏛️ Legalized Site Registration Package

  • Re-engineer Site Master Files (SMF)
    to speak the exact language of Gulf GMP inspectorates.
  • Coordinate embassy legalizations of CPPs and GMP certificates in Berlin.
  • Establish local representation
    by connecting your regulatory team with qualified regional QPPVs.

The “Dual-Hemisphere” Technical Authority

Levant Gate Pharma UG (haftungsbeschränkt) is powered by 14 years of elite cross-functional industry experience:

10 years rooted internally within German Biopharma Quality Assurance and strict GMP systems, combined with 4 years of specialized regional market access.

We speak the exact technical language of your Qualified Persons (QPs) and regulatory affairs teams, while natively navigating the e-portal architectures of Middle Eastern health authorities.

About US

SERVICE MATRIX SUMMARY

Regulatory Compliance Consulting

Technical Focus Area
The European Baseline
The LGP Regulatory Upgrade
Market Clearance Goal

Dossier Structure

(Vision 2030 Mandate)

Standard European eCTD

  • Localized GCC eCTD Format
  • SFDA / MoHAP Portal Acceptance

Stability Data

(Operation 300bn)

Climatic Zone II

  • Climatic Zone IVb Verificatio
  • Heat-Zone Supply Compliance

Traceability

(Industrial Rebuilding)

EU FMD Serialization

  • Tatmeen & RSD Aggregation
  • Flawless Customs Entry

Facility Vetting

(Industrial Rebuilding)

National Bezirksregierung

  • Legalized SMF & Mock Audits
  • Ministry Factory Registration

Frequently Asked Questions on Clinical Market Access

Product registration in the GCC requires meticulous dossier preparation. We assist European manufacturers in formatting their clinical data, stability studies, and pricing certificates to align with the specific eCTD (Electronic Common Technical Document) requirements of the Saudi SFDA, UAE MoHAP, and other regional authorities. We act as the technical liaison between the manufacturer and the local authorized representative.

As a § 52c AMG mediator, LGP does not operate physical warehouses or logistics fleets. We broker the direct contract between the European manufacturer and the Middle Eastern buyer. However, as part of our Quality Assurance protocol, we rigorously audit the designated freight forwarders and regional distributors to ensure they hold valid Good Distribution Practice (GDP) certifications necessary for handling cold-chain biologics.

To maintain the absolute integrity of our compliance shield and eliminate any conflict of interest with primary research ecosystems, LGP enforces a strict, voluntary Therapeutic Negative List. We categorically refuse the mediation of narcotics (BtM), psychoactive substances, unverified nutritional supplements, and aesthetic products. Furthermore, we exclude highly innovative, patented portfolios in Respiratory (LAMA/LABA/ICS) and Cardiometabolism (SGLT2 inhibitors/NOACs). Our resources are dedicated 100% to essential standard generics, vital life-saving therapeutics, and validated medical technology.

Secure Your Technical Consultation

Use the form below to outline your product portfolio (Standard Generics, Biosimilars, or Med-Tech hardware), and our lead consultant will contact your regulatory team within 24 business hours.

Message / Core Regulatory Bottleneck
Product Vertical